Interferon-γ Axis in Graft Arteriosclerosis
Authors:
- 16 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 100 (5) , 622-632
Abstract
Cardiac transplantation is the most effective treatment for advanced heart failure. Despite improvements in immunosuppression therapy that prevent acute rejection, cardiac allografts fail at rates of 3% to 5% per posttransplant year. The hallmark morphological lesion of chronically failing cardiac allografts, also seen in chronic renal and liver graft failure, is luminal stenosis of blood vessels, especially of conduit arteries. Late graft failure results from widespread secondary ischemic injury to the graft parenchyma rather than direct immune-mediated damage. Although this process affects the entire graft vasculature, graft arteriosclerosis is a suitable term to describe the problem because it applies to different types of failing organs and because it emphasizes the central feature, namely an accelerated form of arterial injury and remodeling. The precise pathogenesis of graft arteriosclerosis is unknown. In this review, we make the case that the signature T-helper type 1 cytokine, interferon (IFN)-γ, is a key effector in graft arteriosclerosis, which, together with the IFN-γ–inducing cytokine interleukin-12 and IFN-γ–inducible chemokines such as CXCR3 ligands, constitute a positive feedback loop for T-cell activation, differentiation, and recruitment that we refer to as the IFN-γ axis. We evaluate the evidence to support this hypothesis in clinical observational and experimental animal studies. Additionally, we examine the regulation of IFN-γ production within the artery wall, the effects of IFN-γ on vessel wall cells, and the outcome of therapeutic agents on IFN-γ production and signaling. These observations lead us to suggest that new therapies for graft arteriosclerosis should be optimized which focus on reducing IFN-γ synthesis or actions.Keywords
This publication has 118 references indexed in Scilit:
- Induction of inducible NO synthase in bystander human T cells increases allogeneic responses in the vasculatureProceedings of the National Academy of Sciences, 2007
- Differential effects of insulin‐like growth factor‐1 and atheroma‐associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosisImmunology & Cell Biology, 2006
- Interferon-γ Induces Fas Trafficking and Sensitization to Apoptosis in Vascular Smooth Muscle Cells via a PI3K- and Akt-Dependent MechanismThe American Journal of Pathology, 2006
- Innate Immunity and Organ Transplantation: The Potential Role of Toll-like ReceptorsAmerican Journal of Transplantation, 2005
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology, 2003
- Influence of Interferon-γ on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient MouseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generationBiochemical and Biophysical Research Communications, 1992